Microbio Co., Ltd. researches, develops, manufactures, and trades in biotech drugs and dietary supplements in Taiwan. The company provides MS-20 for fatigue and appetite loss associated with cancer chemotherapy; and Herbiron, which reveals symptoms of iron deficiency anemia in women before menopause and relieved dysmenorrhea. It also involved in the trading of organic foods; sale of beverages; provision of technology development, transfer, and consultation services; and publishing of magazine, as well as offers business consulting services. Microbio Co., Ltd. was incorporated in 2000 and is based in Taipei, Taiwan.
Metrics to compare | 4128 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship4128PeersSector | |
|---|---|---|---|---|
P/E Ratio | −12.1x | −2.3x | 12.0x | |
PEG Ratio | −0.39 | 0.20 | 0.03 | |
Price/Book | 1.0x | 1.7x | 1.5x | |
Price / LTM Sales | 4.8x | 1.5x | 0.9x | |
Upside (Analyst Target) | - | 26.2% | 21.4% | |
Fair Value Upside | Unlock | 16.1% | 11.3% | Unlock |